Power H; Wu J; Turville S; Aggarwal A; Valtchev P; Schindeler A; Dehghani F, 2022, 'Virtual screening and in vitro validation of natural compound inhibitors against SARS-CoV-2 spike protein', Bioorganic Chemistry, vol. 119, pp. 105574, http://dx.doi.org/10.1016/j.bioorg.2021.105574
Aggarwal A; Stella AO; Henry CC; Narayan K; Turville SG, 2022, 'Embedding of HIV Egress within Cortical F-Actin', Pathogens, vol. 11, http://dx.doi.org/10.3390/pathogens11010056
Counoupas C; Johansen MD; Stella AO; Nguyen DH; Ferguson AL; Aggarwal A; Bhattacharyya ND; Grey A; Hutchings O; Patel K; Siddiquee R; Stewart EL; Feng CG; Hansbro NG; Palendira U; Steain MC; Saunders BM; Low JKK; Mackay JP; Kelleher AD; Britton WJ; Turville SG; Hansbro PM; Triccas JA, 2021, 'A single dose, BCG-adjuvanted COVID-19 vaccine provides sterilising immunity against SARS-CoV-2 infection', npj Vaccines, vol. 6, http://dx.doi.org/10.1038/s41541-021-00406-4
Beaton B; Sasson SC; Rankin K; Raedemaeker J; Wong A; Hastak P; Warden A; Ospina Stella A; Aggarwal A; Caterson ID; Phetsouphanh C; Turville S; Kelleher AD; Brilot F; Trotman J, 2021, 'Efficacy of Vaccine BNT162b2 (Pfizer-BioNTech) in Individuals with Waldenstrom's Macroglobulinemia and Follicular Lymphoma in Australia', Blood, vol. 138, pp. 816 - 816, http://dx.doi.org/10.1182/blood-2021-149348
Tea F; Stella AO; Aggarwal A; Darley DR; Pilli D; Vitale D; Merheb V; Lee FXZ; Cunningham P; Walker GJ; Fichter C; Brown DA; Rawlinson WD; Isaacs SR; Mathivanan V; Hoffmann M; Pöhlman S; Mazigi O; Christ D; Rockett RJ; Sintchenko V; Hoad VC; Irving DO; Dore GJ; Gosbell IB; Kelleher AD; Matthews GV; Brilot F; Turville SG, 2021, 'SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants', PLoS Medicine, vol. 18, http://dx.doi.org/10.1371/journal.pmed.1003656
Norman A; Franck C; Christie M; Hawkins PME; Patel K; Ashhurst AS; Aggarwal A; Low JKK; Siddiquee R; Ashley CL; Steain M; Triccas JA; Turville S; MacKay JP; Passioura T; Payne RJ, 2021, 'Discovery of Cyclic Peptide Ligands to the SARS-CoV-2 Spike Protein Using mRNA Display', ACS Central Science, vol. 7, pp. 1001 - 1008, http://dx.doi.org/10.1021/acscentsci.0c01708
Fichter C; Aggarwal A; Wong AKH; McAllery S; Mathivanan V; Hao B; Macrae H; Churchill MJ; Gorry PR; Roche M; Gray LR; Turville S, 2021, 'Modular lentiviral vectors for highly efficient transgene expression in resting immune cells', Viruses, vol. 13, pp. 1170 - 1170, http://dx.doi.org/10.3390/v13061170
Abayasingam A; Balachandran H; Agapiou D; Hammoud M; Rodrigo C; Keoshkerian E; Li H; Brasher NA; Christ D; Rouet R; Burnet D; Grubor-Bauk B; Rawlinson W; Turville S; Aggarwal A; Stella AO; Fichter C; Brilot F; Mina M; Post JJ; Hudson B; Gilroy N; Dwyer D; Sasson SC; Tea F; Pilli D; Kelleher A; Tedla N; Lloyd AR; Martinello M; Bull RA, 2021, 'Long-term persistence of RBD+ memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection', Cell Reports Medicine, vol. 2, pp. 100228, http://dx.doi.org/10.1016/j.xcrm.2021.100228
Ashhurst AS; Tang AH; Fajtová P; Yoon MC; Aggarwal A; Bedding MJ; Stoye A; Beretta L; Pwee D; Drelich A; Skinner D; Li L; Meek TD; McKerrow JH; Hook V; Tseng CT; Larance M; Turville S; Gerwick WH; O'Donoghue AJ; Payne RJ, 2021, 'Potent Anti-SARS-CoV-2 Activity by the Natural Product Gallinamide A and Analogues via Inhibition of Cathepsin L', Journal of Medicinal Chemistry, http://dx.doi.org/10.1021/acs.jmedchem.1c01494
Stelzer-Braid S; Walker GJ; Aggarwal A; Isaacs SR; Yeang M; Naing Z; Ospina Stella A; Turville SG; Rawlinson WD, 2020, 'Virus isolation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for diagnostic and research purposes', Pathology, vol. 52, pp. 760 - 763, http://dx.doi.org/10.1016/j.pathol.2020.09.012
Van Bockel D; Munier CML; Turville S; Badman SG; Walker G; Stella AO; Aggarwal A; Yeang M; Condylios A; Kelleher AD; Applegate TL; Vallely A; Whiley D; Rawlinson W; Cunningham P; Kaldor J; Guy R, 2020, 'Evaluation of commercially available viral transport medium (VTM) for SARS-CoV-2 inactivation and use in point-of-care (POC) testing', Viruses, vol. 12, pp. 1208 - 1208, http://dx.doi.org/10.3390/v12111208
Márquez CL; Lau D; Walsh J; Shah V; McGuinness C; Wong A; Aggarwal A; Parker MW; Jacques DA; Turville S; Böcking T, 2018, 'Kinetics of HIV-1 capsid uncoating revealed by single-molecule analysis', eLife, vol. 7, http://dx.doi.org/10.7554/eLife.34772
Ledger S; Howe A; Turville S; Aggarwal A; Savkovic B; Ong A; Wolstein O; Boyd M; Millington M; Gorry PR; Murray JM; Symonds G, 2018, 'Analysis and dissociation of anti-HIV effects of shRNA to CCR5 and the fusion inhibitor C46', Journal of Gene Medicine, vol. 20, http://dx.doi.org/10.1002/jgm.3006
Aggarwal A; Hitchen TL; Ootes L; McAllery S; Wong A; Nguyen K; McCluskey A; Robinson PJ; Turville SG, 2017, 'HIV infection is influenced by dynamin at 3 independent points in the viral life cycle', Traffic, vol. 18, pp. 392 - 410, http://dx.doi.org/10.1111/tra.12481
Xu Y; Phetsouphanh C; Suzuki K; Aggrawal A; Graff-Dubois S; Roche M; Bailey M; Alcantara S; Cashin K; Sivasubramaniam R; Koelsch KK; Autran B; Harvey R; Gorry PR; Moris A; Cooper DA; Turville S; Kent SJ; Kelleher AD; Zaunders J, 2017, 'HIV-1 and SIV predominantly use CCR5 expressed on a precursor population to establish infection in T follicular helper cells', Frontiers in Immunology, vol. 8, http://dx.doi.org/10.3389/fimmu.2017.00376
Aggarwal A; Turville SG, 2017, 'Resolving the Sites of HIV Entry: Dynamin Networks Hold the Key', Journal of Cell Signaling, vol. 02, http://dx.doi.org/10.4172/2576-1471.1000173
Aggarwal A; Turville SG, 2014, 'Imaging HIV entry and egress', Microbiology Australia
Eyre NS; Fiches GN; Aloia AL; Helbig KJ; McCartney EM; McErlean CSP; Li K; Aggarwal A; Turville SG; Beard MR, 2014, 'Dynamic imaging of the hepatitis C virus NS5A protein during a productive infection', Journal of Virology, vol. 88, pp. 3636 - 3652, http://dx.doi.org/10.1128/JVI.02490-13
Aggarwal A; Mcallery S; Turville S, 2013, 'Revising the role of myeloid cells in HIV pathogenesis', Current HIV/AIDS Reports, vol. 10, pp. 3 - 11, http://dx.doi.org/10.1007/s11904-012-0149-1
Aggarwal A; Saksena MM; Boadle RA; Alam W; Kelly BJ; Diefenbach RJ; Cunningham AL, 2012, 'Ultrastructural visualization of individual tegument protein dissociation during entry of herpes simplex virus type 1 into human and rat dorsal root ganglion neurons.', Journal of Virology, vol. 86, pp. 6123 - 6137, http://dx.doi.org/10.1128/JVI.07016-11
Aggarwal A; Iemma T; Shih I; Newsome TP; Mcallery S; Cunningham A; Turville S, 2012, 'Mobilization of HIV spread by diaphanous 2 dependent filopodia in infected dendritic cells', PLoS Pathogens, vol. 8, pp. e1002762, http://dx.doi.org/10.1371/journal.ppat.1002762
Miranda-Saksena M; Boadle RA; Aggarwal A; Tijono B; Rixon FJ; Diefenbach RJ; Cunningham AL, 2009, 'Herpes simplex virus utilizes the large secretory vesicle pathway for anterograde transport of tegument and envelope proteins and for viral exocytosis from growth cones of human fetal axons', Journal of Virology, vol. 83, pp. 3197 - 3199, http://dx.doi.org/10.1128/JVI.01579-08
Capraro A; Wong SL; Adhikari A; Allan KM; Patel HR; Zhong L; Raftery M; Jaffe A; Yeang M; Aggarwal A; Wu L; Pandzic E; Whan RM; Turville S; Vittorio O; Bull RA; Kaakoush N; Rawlinson WD; Tedla N; Vafaee F; Waters SA, 'Ageing impairs the airway epithelium defence response to SARS-CoV-2', , http://dx.doi.org/10.1101/2021.04.05.437453
Aggarwal A; Ospina Stella A; Henry C; Narayan K; Turville SG, 'HIV corruption of the Arp2/3-Cdc42-IQGAP1 axis to hijack cortical F-Actin to promote cell-cell viral spread', , http://dx.doi.org/10.1101/2019.12.13.873612
Xu Y; Bailey M; Phetsouphanh C; Harvey R; Turville S; Aggarwal A; Wong A; Suzuki K; Graff-Dubois S; Autran B; Moris A; Munier ML; Koelsch K; Kent S; Zaunders J; Kelleher A, 2016, 'Accumulation of follicular T Helper (Tfh) cells, despite preferential infection, allows establishment of a large and unexpected viral reservoir during HIV infection', in EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY-BLACKWELL, Melbourne, AUSTRALIA, Vol. 46, pp. 264 - 264, presented at International Congress of Immunology (ICI), Melbourne, AUSTRALIA, 21 August 2016 - 26 August 2016, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383610400533&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Ashhurst AS; Tang AH; Fajtová P; Yoon M; Aggarwal A; Stoye A; Larance M; Beretta L; Drelich A; Skinner D; Li L; Meek TD; McKerrow JH; Hook V; Tseng C-TK; Turville S; Gerwick WH; O'Donoghue AJ; Payne RJ, 2020, Potent in vitro anti-SARS-CoV-2 activity by gallinamide A and analogues via inhibition of cathepsin L., http://dx.doi.org/10.1101/2020.12.23.424111
Counoupas C; Johansen MD; Stella AO; Nguyen DH; Ferguson AL; Aggarwal A; Bhattacharyya ND; Grey A; Patel K; Siddiquee R; Stewart EL; Feng CG; Hansbro NG; Palendira U; Steain MC; Saunders BM; Low JKK; Mackay JP; Kelleher AD; Britton WJ; Turville SG; Hansbro PM; Triccas JA, A single dose, BCG-adjuvanted COVID-19 vaccine provides sterilizing immunity against SARS-CoV-2 infection in mice, http://dx.doi.org/10.1101/2020.12.10.419044
Johansen-Leete J; Ullrich S; Fry SE; Frkic R; Bedding MJ; Aggarwal A; Ashhurst AS; Ekanayake KB; Mahawaththa MC; Sasi VM; Passioura T; Larance M; Otting G; Turville S; Jackson CJ; Nitsche C; Payne RJ, Discovery of Antiviral Cyclic Peptides Targeting the Main Protease of SARS-CoV-2 via mRNA Display, http://dx.doi.org/10.1101/2021.08.23.457419
Counoupas C; Pino P; Stella AO; Ashley C; Lukeman H; Bhattacharyya ND; Tada T; Anchisi S; Metayer C; Martinis J; Aggarwal A; Dcosta BM; Kint J; Wurm MJ; Landau NR; Steain M; Turville SG; Wurm FM; David SA; Triccas JA, Neutralising antibodies against the SARS-CoV-2 Delta variant induced by Alhydroxyquim-II-adjuvanted trimeric spike antigens, http://dx.doi.org/10.1101/2021.08.18.456891
Norman A; Franck C; Christie M; Hawkins PME; Patel K; Ashhurst AS; Aggarwal A; Low JKK; Siddiquee R; Ashley CL; Steain M; Triccas JA; Turville S; Mackay JP; Passioura T; Payne RJ, Discovery of Cyclic Peptide Ligands to the SARS-CoV-2 Spike Protein using mRNA Display, http://dx.doi.org/10.1101/2020.12.22.424069
Garcia-Valtanen P; Hope CM; Masavuli MG; Lip Yeow AE; Balachandran H; Mekonnen ZA; Al-Delfi Z; Abayasingam A; Agapiou D; Stella AO; Aggarwal A; Gummow J; Ferguson C; O’Connor S; McCartney EM; Lynn DJ; Maddern G; Gowans EJ; Reddi BAJ; Shaw D; Kok-Lim C; Turville SG; Beard MR; Weiskopf D; Sette A; Bull RA; Barry SC; Grubor-Bauk B, COVID-19 convalescents exhibit deficient humoral and T cell responses to variant of concern Spike antigens at 12 month post-infection, http://dx.doi.org/10.1101/2021.11.08.21266035
Loo L; Waller MA; Cole AJ; Stella AO; Moreno CL; Denes CE; Hamoudi Z; Chung F; Aggarwal A; Low JKK; Patel K; Siddique R; Mackay J; Turville S; Hesselson D; Neely GG, LRRC15 suppresses SARS-CoV-2 infection and controls collagen production, http://dx.doi.org/10.1101/2021.11.09.467981
